![](/img/cover-not-exists.png)
Phase 1 Trial of Carfilzomib + Melphalan (CarMel) Conditioning and Autologous Hematopoietic Stem Cell Transplantation (AHSCT) for Relapsed Multiple Myeloma (MM)
Costa, Luciano J., Landau, Heather, Venkata, Jagadish K., Kang, Yubin, Koehne, Guenther, Chung, David J., Lendvai, Nikoletta, Bentz, Tricia, Giralt, Sergio A.Volume:
20
Language:
english
Journal:
Biology of Blood and Marrow Transplantation
DOI:
10.1016/j.bbmt.2013.12.254
Date:
February, 2014
File:
PDF, 200 KB
english, 2014